Head to head
Humana vs UnitedHealth
Side-by-side on the measures that matter, with a plain-English read. Full detail: HUM · UNH
HUM
Humana
390.00+2.63%
1-year price shape — +77% over the period
Quant Rating C · 94/100
vs
UNH
UnitedHealth
339.85+2.84%
1-year price shape — +11% over the period
Quant Rating D · 55/100
1-year performance, rebased to 100
UnitedHealth edges it on the scoreable measures. UnitedHealth trades cheapest on trailing earnings; UnitedHealth pays the highest dividend yield; UnitedHealth earns the most per share.
| HUM | UNH | |
|---|---|---|
| Snapshot | ||
| Sector | Healthcare Plans | Healthcare Plans |
| Last price | 390.00 | 339.85 |
| Change today | +2.63% | +2.84% |
| 1-year return | +76.6% | +11.3% |
| Market cap | $46.84B | $304.51B |
| 52-week range | 161.56 – 462.87 | 252.95 – 458.79 |
| Valuation | ||
| P/E (TTM) | 38.05 | 19.40 |
| P/E percentile, own 5-yr range | 95th | 41st |
| P/B | 2.49 | 3.10 |
| Dividend yield | 0.68% | 2.67% |
| Profitability & growth | ||
| EPS (TTM) | 9.84 | 13.23 |
| Net profit (TTM) | $1.18B | $11.85B |
| Revenue (TTM) | $154.19B | $449.66B |
| Provider revenue period date | 2026-09-29 | 2026-09-29 |
| Revenue growth (YoY) | +26.1% | -0.4% |
| Gross margin | -- | 19.8% |
| Operating margin | -- | 5.3% |
| Net margin | 0.8% | 3.5% |
| Free cash flow (TTM) | $3.14B | $22.83B |
| Provider cash-flow period date | 2026-09-29 | 2026-09-29 |
| Ownership & sentiment | ||
| Institutional ownership | 98.6% | 88.8% |
| Insider activity (12mo) | 33 buy / 12 sell | 44 buy / 5 sell |
| Short interest (% of float) | 2.3% | 1.6% |
| Analyst consensus | 76% buy / 24% hold (21) | 88% buy / 12% hold (17) |
| Analyst price target | $514 (+32%) | $485 (+43%) |
| StockVane view | ||
| StockVane Quant Rating | C (94) | D (55) |
| Company | ||
| Employees | 67,060 | 390,000 |
| Founded | 1964 | 1977 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.